Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis.
Meyer A, Troyanov Y, Korathanakhun P, Landon-Cardinal O, Leclair V, Allard-Chamard H, Bourré-Tessier J, Makhzoum JP, Isabelle C, Larue S, Grand'Maison F, Massie R, Page ML, Mansour AM, Routhier N, Zarka F, Roy F, Sonnen J, Satoh M, Fritzler M, Hudson M, Senécal JL, Karamchandani J, Ellezam B, O'Ferrall E. Meyer A, et al. Among authors: massie r. Neuromuscul Disord. 2023 Feb;33(2):169-182. doi: 10.1016/j.nmd.2022.12.001. Epub 2022 Dec 5. Neuromuscul Disord. 2023. PMID: 36649672
Autoimmune peripheral neuropathies.
Bourque PR, Chardon JW, Massie R. Bourque PR, et al. Among authors: massie r. Clin Chim Acta. 2015 Sep 20;449:37-42. doi: 10.1016/j.cca.2015.02.039. Epub 2015 Mar 4. Clin Chim Acta. 2015. PMID: 25748038 Review.
Polymerase gamma 1 mutations: clinical correlations.
Milone M, Massie R. Milone M, et al. Among authors: massie r. Neurologist. 2010 Mar;16(2):84-91. doi: 10.1097/NRL.0b013e3181c78a89. Neurologist. 2010. PMID: 20220442 Review.
Diabetic Cranio-Cervico-Radiculoplexus Neuropathy.
Gupta G, Massie R, Doherty TJ, Bourque PR, Radhakrishna M, Finlayson RJ, Besemann M, Simantirakis E, Dyck PJB. Gupta G, et al. Among authors: massie r. PM R. 2015 Nov;7(11):1189-1193. doi: 10.1016/j.pmrj.2015.05.003. Epub 2015 May 12. PM R. 2015. PMID: 25978945
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Meininger V, Genge A, van den Berg LH, Robberecht W, Ludolph A, Chio A, Kim SH, Leigh PN, Kiernan MC, Shefner JM, Desnuelle C, Morrison KE, Petri S, Boswell D, Temple J, Mohindra R, Davies M, Bullman J, Rees P, Lavrov A; NOG112264 Study Group. Meininger V, et al. Lancet Neurol. 2017 Mar;16(3):208-216. doi: 10.1016/S1474-4422(16)30399-4. Epub 2017 Jan 28. Lancet Neurol. 2017. PMID: 28139349 Free article. Clinical Trial.
Teaching NeuroImages: Sneddon syndrome.
Almutlaq A, Alshurem M, Levesque-Roy M, Massie R. Almutlaq A, et al. Among authors: massie r. Neurology. 2019 Sep 17;93(12):e1227-e1228. doi: 10.1212/WNL.0000000000008137. Neurology. 2019. PMID: 31527109 No abstract available.
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
100 results